ArticleExploration of targeted anti-tumor therapy2023

Aflatoxin B1-DNA adducts modify the effects of post-operative adjuvant transarterial chemoembolization improving hepatocellular carcinoma prognosis.

Liyan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.